Cyclophosphamide, Radiation Therapy, and Poly ICLC in Treating Patients With Unresectable, Recurrent, Primary, or Metastatic Liver Cancer

NCT00553683 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer
Colorectal Cancer
Gastric Cancer
Liver Cancer
Melanoma (Skin)
Metastatic Cancer
Ovarian Cancer
Pancreatic Cancer

Interventions

DRUG: cyclophosphamide
DRUG: poly ICLC
PROCEDURE: hepatic artery embolization
RADIATION: 3-dimensional conformal radiation therapy

Sponsor

Rutgers, The State University of New Jersey